Meet Dr. Mario Sznol

Transcript

• 00:00Amario Snow Lima medical oncologist.
• 00:02I treat Melanoma and renal cell carcinoma.
• 00:05My major interest outside of
• 00:06these two diseases is really the
• 00:08development of immune therapies.
• 00:10I've been working on this probably
• 00:12for the past 35 years and it turns
• 00:14out that Melanoma and kidney cancer,
• 00:16which are the two diseases that are treat,
• 00:19are the most responsive to immune therapies,
• 00:21or at least there was a time when those
• 00:24were the only two diseases that were
• 00:26really responsive to immune therapies.
• 00:28With these new drugs that that.
• 00:31We helped develop.
• 00:32Immunotherapy is now used in
• 00:33almost every kind of cancer,
• 00:35but initially it was Melanoma and
• 00:37kidney cancer and that's why I was
• 00:40drawn to those two diseases and I've
• 00:42stayed with that for my entire career.
• 00:45We're very satisfied that
• 00:46approximately 50% of the patients
• 00:48can be really treated effectively
• 00:50with the medicines that we have now,
• 00:52but the truth is,
• 00:53the other 50% don't do well and can
• 00:56possibly die of their menist attic
• 00:58disease if not treated effectively.
• 01:00Research is really important in finding.
• 01:02A more effective treatments
• 01:04for those other 50%.
• 01:06So our clinical research is really
• 01:08focused around finding new medications
• 01:10that can effectively treat those
• 01:12that don't respond to the group
• 01:14of medications that work now,
• 01:15and we integrate our clinical
• 01:17research with our clinical practice.
• 01:19We feel that for the subset of patients
• 01:21that don't have viable standard of care,
• 01:24alternative options we should be offering
• 01:26them the best available investigational
• 01:27therapies that are out there.
• 01:29We take a very much a team approach
• 01:32to the treatment of our patients
• 01:34and we encourage people to ask
• 01:36questions and we try and spend as
• 01:38much time with them at the beginning.
• 01:42Of each patient journey at the at
• 01:44very first visit to answer all
• 01:46the questions that they have.
• 01:47But the other thing that we try and
• 01:49do is we try and answer the questions
• 01:52that they may not know to ask,
• 01:54so as much as possible we we try and
• 01:56have a very long conversation and I
• 01:59go through all aspects of the disease
• 02:01and Natural History, the treatment,
• 02:03how we monitor for recurrence.
• 02:04A number of visits.
• 02:05I also introduce them to our practice
• 02:07nurses which are in really important
• 02:09part of our practice because those that's
• 02:11the interface between the outside and.
• 02:13And into our clinic.